Products

The Dapivirine extended-release monthly film, being developed by the Rohan Pharmaceutics laboratory at the University of Pittsburgh School of Pharmacy and Magee-Womens Research Institute under the VALUE (Vaginal film as A Low-cost, User-administered, and Extended-release product) project, is a game-changing female-controlled product providing monthly protection against HIV infection. The film is simple, portable, discreet, applicator-free, scalable, low cost, and bioerodible, with minimal package waste.

The non-antiretroviral, non-hormonal intravaginal ring developed by the Oak Crest Institute of Science is a multipurpose prevention technology with a 1-to 3-month duration combining two novel, luminally acting active pharmaceutical ingredients: (1) an anti-viral with unique mechanisms of action against HIV, HSV, and HPV; and (2) a contraceptive and would be a game-changer product for women who desire non-hormonal contraceptives with prevention of HIV and other sexually transmitted infections in a single product.

The Tenofovir alafenamide/ Elvitegravir (TAF/EVG) Fast Dissolving Insert is developed by CONRAD.  After extensive end-user research, a TAF/EVG dual-compartment insert for PrEP or PEP user-controlled, on-demand use and Multipurpose Prevention Technology against HIV and HSV, will be advanced clinically, providing a user-friendly on-demand product.